Narendra D. Lalwani, Ph.D., FAHA, DABT
Overview
Narendra D. Lalwani, Ph.D., FAHA, DABT received an average of $2M in total compensation, including $395K in salary, at Esperion Therapeutics from 2015 to 2018.
2018Esperion TherapeuticsExecutive Vice President, Research and Development
2017Esperion TherapeuticsExecutive Vice President, Research and Development and Chief Operating Officer
2016Esperion TherapeuticsExecutive Vice President, Research and Development and Chief Operating Officer
2015Esperion TherapeuticsExecutive Vice President, Research and Development and Chief Operating Officer
Source: SEC filings on April 18, 2019 and April 13, 2018.
Related executives
We found 11 more executives who work or worked at Esperion Therapeutics.
Sheldon Koenig
Esperion Therapeutics
Chief Executive Officer
JoAnne Foody
Esperion Therapeutics
Chief Medical Officer
Eric Warren
Esperion Therapeutics
Chief Commercial Officer
Benjamin Looker
Esperion Therapeutics
General Counsel
Tim Mayleben
Esperion Therapeutics
Chief Executive Officer
Richard Bartram
Esperion Therapeutics
Chief Financial Officer
Ashley Hall
Esperion Therapeutics
Former Chief Development Officer
Mark Glickman
Esperion Therapeutics